Richard Payerchin

Examining where the money went.

Do investors sacrifice patient care for profits?

Medical cost data is part of Fed report on national economic well-being.

Potential for growth is a key factor.

White House announces Medicaid drug cost audits while House committee examines pricing process.

New tool aims to become sustainable program for treating obesity as a disease state, not just other associated conditions.

Who controls oversight and compliance?

Family physicians endorse new advisory on teens’ constant use of tech and effects their brains, attitudes, and time with family and friends.

Recent developments drive price breaks for necessary substance.

CDC publishes latest figures on private and public coverage from 2019 to last year.

Medical students, foreign-trained doctors who don’t match into residencies could be licensed to treat patients while gaining skills.

Physicians debate merits of face covers as virus becomes endemic in the population.

Whistleblowers can speak out about fraud.

Lawmakers introduce bills to ‘guarantee health care as a fundamental human right to all people in the U.S.’

Economic stability included for first time in 10-year survey.

Study on prescriptions suggests how doctors, patients, real-time price tools, and pharmacists can work together.

Federal regulations are not the only rules.

Government trade watchdogs continue scrutiny of drug prices.

Private equity investment firms come in all shapes and sizes.

It can be a good relationship sometimes.

Defendants face up to 20 years in prison, according to Department of Justice.

‘Nutrition for Precision Health’ seeks out how each body responds differently to food.

Primary care docs are on the front lines to help patients avoid bogus health claims.

Physicians and regulators will have access to huge amounts of data. How will that help patients?

It’s common in health care to use third-party software, but exposing information prompts a warning from HHS’ cybersecurity agency.

A former assistant U.S. attorney offers legal perspectives on federal and state regulations and compliance.

Here’s what to know, according to the federal health agency.

AMA study examines legal risk varies by several factors, with short-term risk down in 2022.

However, questions remain about privacy and accuracy.

Latest Consumer Price Index report out as White House, Congressional Republicans wrangle over national debt ceiling.